Champions Oncology targets sequential revenue growth and margin expansion as radiopharma and data platforms advance (NASDAQ:CSBR)

Core Insights - The earnings call insights are derived from earnings call transcripts and other content available on the Seeking Alpha website, generated by an AI tool without editorial review [1] Group 1 - The insights are intended for informational purposes only and do not account for individual objectives or financial situations [1] - Seeking Alpha does not provide personalized investment advice and is not a licensed securities dealer or investment adviser [1]